Teiko.bio

About:

Teiko.bio is an immune profiling platform that enables clinicians to make informed decisions around patient response.

Twitter/X: teikobio

Top Investors: Founders Fund, HOF Capital, Global Founders Capital, Darian Shirazi, EPIC Ventures

Description:

Teiko.bio is an immune profiling platform that enables clinicians to make informed decisions around patient response. The company was founded in 2020 and is based in Salt Lake City, Utah.

Total Funding Amount:

$11.6M

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

Salt Lake City, Utah, United States

Founded Date:

2020-01-01

Contact Email:

info(AT)teiko.bio

Founders:

Matthew Spitzer, Ramji Srinivasan

Number of Employees:

1-10

Last Funding Date:

2022-03-29

IPO Status:

Private

Industries: